Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CYP3A4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CYP3A4 is a gene implicated in neurodegeneration research. Key relationships include: associated with, activates, regulates. Associated with ALS, Als, Alzheimer. Connected to 175 entities in the SciDEX knowledge graph.
| Gene Symbol | CYP3A4 |
| Full Name | Cytochrome P450 3A4 |
| Chromosome | 7q21.1 |
| Function | CYP3A4 encodes cytochrome P450 3A4, which plays a critical role in |
| Primary Expression | the liver and intestinal mucosa |
| Pathways | Oxidative Stress |
| UniProt ID | [P08684](https://www.uniprot.org/uniprot/P08684) |
| Ensembl ID | ENSG00000123338 |
| OMIM | 171696 |
| GeneCards | CYP3A4 |
| Human Protein Atlas | CYP3A4 |
| Associated Diseases | ALS, Alzheimer, Alzheimer'S Disease, Anxiety |
| Known Drugs/Compounds | anxiolytic drugs |
| Interactions | JUN, PDK1, EGFR, ERCC3, CEBPB, AKT |
| KG Connections | 311 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
CYP3A4["CYP3A4<br/>Cytochrome P450<br/>Drug Metabolizing Enzyme"]
MTOR["mTOR<br/>Mechanistic Target<br/>of Rapamycin"]
JUN["c-JUN<br/>Transcription<br/>Factor"]
SNCA["SNCA<br/>alpha-Synuclein<br/>Protein"]
ABCB1["ABCB1<br/>P-glycoprotein<br/>Drug Efflux Pump"]
ABCG2["ABCG2<br/>BCRP Transporter<br/>Drug Efflux"]
SLC6A2["SLC6A2<br/>Norepinephrine<br/>Transporter"]
SLC6A3["SLC6A3<br/>Dopamine<br/>Transporter"]
Epigenetic["Epigenetic<br/>Regulation<br/>Pathway"]
Alzheimer["Alzheimer's<br/>Disease"]
Parkinson["Parkinson's<br/>Disease"]
ALS["ALS<br/>Motor Neuron<br/>Disease"]
Dementia["Dementia<br/>Cognitive Decline"]
Depression["Depression<br/>Mood Disorder"]
MS["Multiple<br/>Sclerosis"]
Drug_Metabolism["Drug Metabolism<br/> and Clearance"]
BBB_Transport["Blood-Brain Barrier<br/>Drug Transport"]
CYP3A4 --|"regulates"|--> MTOR
CYP3A4 --|"activates"|--> JUN
CYP3A4 --|"metabolizes"|--> Drug_Metabolism
CYP3A4 --|"coordinates with"|--> ABCB1
CYP3A4 --|"coordinates with"|--> ABCG2
MTOR --|"influences"|--> Alzheimer
JUN --|"promotes"|--> Parkinson
SNCA --|"associated with"|--> Parkinson
Drug_Metabolism --|"affects"|--> BBB_Transport
ABCB1 --|"controls"|--> BBB_Transport
ABCG2 --|"controls"|--> BBB_Transport
SLC6A2 --|"regulates"|--> Depression
SLC6A3 --|"regulates"|--> Parkinson
BBB_Transport --|"therapeutic efficacy"|--> Dementia
Epigenetic --|"modulates"|--> CYP3A4
CYP3A4 --|"dual role"|--> ALS
CYP3A4 --|"associated with"|--> MS
style CYP3A4 fill:#006494
style MTOR fill:#4a1a6b
style JUN fill:#4a1a6b
style ABCB1 fill:#4a1a6b
style ABCG2 fill:#4a1a6b
style Drug_Metabolism fill:#1b5e20
style BBB_Transport fill:#1b5e20
style Epigenetic fill:#1b5e20
style Alzheimer fill:#5d4400
style Parkinson fill:#5d4400
style ALS fill:#5d4400
style Dementia fill:#5d4400
style Depression fill:#ef5350
style MS fill:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| anxiolytic drugs | modulates | drug | 0.80 |
| clopidogrel resistance | contributes_to | phenotype | 0.80 |
| Alzheimer | associated_with | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Anxiety | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cirrhosis | activates | disease | 0.65 |
| Carcinoma | activates | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Als | protects_against | disease | 0.65 |
| Parkinson | protects_against | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Cirrhosis | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Dementia | interacts_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Diabetes | regulates | disease | 0.65 |
| Metabolic Syndrome | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Nafld | associated_with | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| Fatty Liver | regulates | disease | 0.65 |
| Type 2 Diabetes | regulates | disease | 0.65 |
| Insulin Resistance | regulates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Vascular Dementia | transports | disease | 0.65 |
| Alzheimer | transports | disease | 0.65 |
| Dementia | transports | disease | 0.65 |
| ALS | transports | disease | 0.65 |
| Frontotemporal Dementia | transports | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Frontotemporal Dementia | therapeutic_target | disease | 0.65 |
| Vascular Dementia | therapeutic_target | disease | 0.65 |
| MTOR | regulates | protein | 0.64 |
| ABCG2 | associated_with | gene | 0.60 |
| ADRB2 | associated_with | gene | 0.60 |
| SNCA | associated_with | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| SLC6A3 | associated_with | gene | 0.60 |
| ABCB1 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Mi-891 | downregulates | drug | 0.90 |
| PXR | activates | protein | 0.85 |
| MAOB | associated_with | gene | 0.60 |
| GABRA1 | associated_with | gene | 0.60 |
| CHAT | associated_with | gene | 0.60 |
| CYP2D6 | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| HMGCR | associated_with | gene | 0.60 |
| OPRM1 | associated_with | gene | 0.60 |
| SLC30A8 | associated_with | gene | 0.60 |
| COMT | associated_with | gene | 0.60 |
| NBEA | associated_with | gene | 0.60 |
| HTR2C | associated_with | gene | 0.60 |
| ADRA2A | associated_with | gene | 0.60 |
| BCHE | associated_with | gene | 0.60 |
| SLC6A2 | associated_with | gene | 0.60 |
| SLC6A3 | associated_with | gene | 0.60 |
| ABCB1 | associated_with | gene | 0.60 |
| SLC6A4 | associated_with | gene | 0.60 |
| GSTP1 | associated_with | gene | 0.60 |
| DRD2 | associated_with | gene | 0.60 |
| EGF | activates | gene | 0.60 |
| ADRB2 | associated_with | gene | 0.60 |
| ABCG2 | associated_with | gene | 0.60 |
| LRRK2 | associated_with | gene | 0.60 |
| GCH1 | associated_with | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| GPNMB | associated_with | gene | 0.60 |
| PDK1 | activates | gene | 0.60 |
| ERCC3 | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| MTOR | expressed_in | gene | 0.60 |
| AKT | associated_with | gene | 0.60 |
| CEBPB | associated_with | gene | 0.60 |
| GPNMB | transports | gene | 0.60 |
| NUCKS1 | transports | gene | 0.60 |
| CYP2D6 | transports | gene | 0.60 |
| SLC6A2 | transports | gene | 0.60 |
| SNCA | transports | gene | 0.60 |
| GCH1 | transports | gene | 0.60 |
| DRD2 | transports | gene | 0.60 |
| SLC6A3 | transports | gene | 0.60 |
| LRRK2 | transports | gene | 0.60 |
| APOE | transports | gene | 0.60 |
| ABCB1 | transports | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| CEBPB | activates | gene | 0.60 |
| SLC6A4 | transports | gene | 0.60 |
| PPAR | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||